Patents Assigned to Reviva Pharmaceuticals, Inc.
-
Patent number: 10441590Abstract: The present invention provides a method of using arylpiperazine derivatives for treating pulmonary hypertension. The method comprises a step of administering to a patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.Type: GrantFiled: July 7, 2017Date of Patent: October 15, 2019Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Marc Cantillon, Ellen M. Wallis, Seema Rani Bhat
-
Patent number: 9975862Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,Type: GrantFiled: March 27, 2017Date of Patent: May 22, 2018Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Patent number: 9907803Abstract: The present invention provides a method of using arylpiperazine derivatives for treating attention deficit hyperactivity disorder (ADHD). The method comprises a step of administering to a patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.Type: GrantFiled: October 4, 2016Date of Patent: March 6, 2018Assignee: REVIVA PHARMACEUTICALS, INC.Inventor: Laxminarayan Bhat
-
Patent number: 9695116Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: GrantFiled: December 31, 2015Date of Patent: July 4, 2017Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Kouacou Adiey, Seema Rani Bhat
-
Patent number: 9604944Abstract: The present invention provides arylpiperazine derivatives having Formula 1a as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,Type: GrantFiled: February 8, 2016Date of Patent: March 28, 2017Assignee: REVIVA PHARMACEUTICALS, INC.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Patent number: 9302981Abstract: The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.Type: GrantFiled: March 10, 2014Date of Patent: April 5, 2016Assignee: REVIVA PHARMACEUTICALS, Inc.Inventors: Laxminarayan Bhat, Seema Rani Bhat
-
Patent number: 9296681Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: GrantFiled: November 6, 2013Date of Patent: March 29, 2016Assignee: REVIVA PHARMACEUTICALS, INC.Inventors: Laxminarayan Bhat, Seema Bhat
-
Patent number: 9255076Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,Type: GrantFiled: February 24, 2015Date of Patent: February 9, 2016Assignee: REVIVA PHARMACEUTICALS, INC.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Patent number: 9238625Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: GrantFiled: December 31, 2012Date of Patent: January 19, 2016Assignee: REVIVA PHARMACEUTICALS, INC.Inventors: Laxminarayan Bhat, Kouacou Adiey, Seema Rani Bhat
-
Patent number: 9096515Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: GrantFiled: September 26, 2013Date of Patent: August 4, 2015Assignee: REVIVA PHARMACEUTICALS, INC.Inventors: Laxminarayan Bhat, Kouacou Adiey
-
Patent number: 8980883Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.Type: GrantFiled: September 17, 2014Date of Patent: March 17, 2015Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Patent number: 8859552Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.Type: GrantFiled: June 10, 2013Date of Patent: October 14, 2014Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Publication number: 20140194508Abstract: The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.Type: ApplicationFiled: March 10, 2014Publication date: July 10, 2014Applicant: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan BHAT, Seema Rani Bhat
-
Publication number: 20140155392Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.Type: ApplicationFiled: June 10, 2013Publication date: June 5, 2014Applicant: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
-
Patent number: 8669285Abstract: The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications.Type: GrantFiled: April 19, 2013Date of Patent: March 11, 2014Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Seema Rani Bhat
-
Publication number: 20140066500Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: ApplicationFiled: November 6, 2013Publication date: March 6, 2014Applicant: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan BHAT, Seema BHAT
-
Publication number: 20140024709Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: ApplicationFiled: September 26, 2013Publication date: January 23, 2014Applicant: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan BHAT, Kouacou ADIEY
-
Publication number: 20140024679Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: ApplicationFiled: December 31, 2012Publication date: January 23, 2014Applicant: Reviva Pharmaceuticals, Inc.Inventor: Reviva Pharmaceuticals, Inc.
-
Patent number: 8604244Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.Type: GrantFiled: July 1, 2011Date of Patent: December 10, 2013Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Kouacou Adiey
-
Patent number: 8580822Abstract: The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.Type: GrantFiled: June 8, 2012Date of Patent: November 12, 2013Assignee: Reviva Pharmaceuticals, Inc.Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra